FANCD2 and Friedreich ataxia: FANCD2 monoubiquitination is a hallmark of the activation of the FA pathway, and un-monoubiquitinated/inactivated FANCD2 accounts for nearly 95% of FA cases, and is one of the major factors accounting for the tumorigenecity of an impaired FA pathway [14, 15, 21].